4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022560
CHIEF OPERATING OFFICER sold 17,500 shares at $26.91 ($470,925)
- CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2024-08-27 | Option exercise 10b5-1 | +10,000 | $1.59 | $15,900 | 137,411 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2024-08-27 | Sale 10b5-1 | −17,500 | $26.91 | $470,925 | 119,911 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2024-08-27 | Option exercise · Share Option 10b5-1 | −10,000 | 46,017 | D | ||
| Open-market sales · 17,500 sh · avg $26.91 · $470,925 | |||||||
Loading xslF345X05/form4-08292024_080838.xml…